Qinghai Delingha Xiehe Solar PV Power Generation Project (GS3341 Conversion CER to VER)
GS-1370 ↗ · current registry ID: GS5404
#1188of 1935 in Renewable energy#697of 1084 in China#975of 1801 in Gold Standard (GS)#925of 1287 in ACM0002
Audit Analysis
A Gold Standard solar PV project in Qinghai, China, verified by LGAI Technological Center with a jurisdictional baseline and no material findings. However, the extracted record lacks critical additionality documentation, buffer pool details, and baseline reassessment timing, creating meaningful evidence gaps. The project is a CER-to-VER conversion with a 2013–2015 monitoring window, and the limited document set (two reports, no PDD) constrains full assessment.
Red Flags
- Additionality test type and VVB confirmation are not stated in any available document, leaving a core Gold Standard requirement unverified in the extracted record
- Only two documents (monitoring report and verification report) are available; the PDD and any subsequent monitoring reports are absent, limiting the ability to assess the full project lifecycle
Credit Vintages Exhausted
| Issued | Retired | Available | ||
|---|---|---|---|---|
| 2013 | 49,872 | 49,872 | 0 | |
| 2014 | 48,167 | 48,167 | 0 | |
| 2015 | 25,653 | 25,653 | 0 | |
| Total | 123,692 | 123,692 | 0 |
Risk Indicators
Test type and VVB confirmation not stated in available documents
Solar PV avoidance project; no biogenic reversal risk
0% deduction, deemed negligible — consistent with solar PV
Jurisdictional method stated; reassessment timing not documented
Safeguards and benefit sharing mentioned; FPIC and grievance mechanism not stated
CORSIA and CCP statuses not stated; dual-channel risk unconfirmed
⚑ Dispute this rating
Are you the project owner?
Metadata correction (free)
Name, country, marketplace or links incorrect? Let us know.
Does not modify the score.
[email protected] →Pipeline re-run with new documents
Have updated documentation not yet included? You can request a new run of the pipeline with the new inputs.
Submit Documents →Share this rating
